GlycoPharma Holding ApS
CVR 39691558 · Private limited company (ApS) · Active · Low risk
GlycoPharma Holding ApS is a Private limited company (ApS), founded on , based in Odense SØ. The company is registered in the industry ikke-finansielle holdingselskaber. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 7 annual reports have been published. The latest annual report (30 Jun 2025) shows equity of DKK 684k and a net result of DKK -12k. CEO: Anders Boysen.
Bankruptcy risk for GlycoPharma Holding ApS
0.0 × the average (1.41%) · higher risk than 27% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 39691558
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (8 years)
- Address
- Rørhatten 4
5220 Odense SØ - Municipality
- Odense
- Industry
- Ikke-finansielle holdingselskaber (642120)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber - Share capital
- DKK 138k
- Auditor
- PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 7 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 85.2% |
| Current ratio | 1% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 3 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -13k | DKK -16k | DKK -14k |
| Net profit | DKK -12k | DKK -15k | DKK -14k |
| Equity | DKK 684k | DKK 697k | DKK 584k |
| Total assets | DKK 803k | DKK 806k | DKK 690k |
| Cash | DKK 881 | DKK 3,822 | – |
| Short-term debt | DKK 119k | DKK 109k | – |
| Avg. employees | 0 | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jul 2024 – 30 Jun 2025 | 175 | ||
| 1 Jul 2023 – 30 Jun 2024 | 171 | ||
| 1 Jul 2022 – 30 Jun 2023 | 125 | ||
| 1 Jul 2021 – 30 Jun 2022 | 123 | ||
| 1 Jul 2020 – 30 Jun 2021 | 149 | ||
| 1 Jul 2019 – 30 Jun 2020 | 132 | ||
| 28 Jun 2018 – 30 Jun 2019 | 131 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Anders Boysen | Current | |
| Owner (5%) | SCIENCE VENTURES DENMARK A/S | Current | |
| Owner (33%) | Boysen Bio ApS | Current | |
| Owner (15%) | Zahle Holding ApS | Current | |
| Owner (10%) | Røssel Invest APS | Current | |
| Owner (10%) | JMJ Holding ApS | Current | |
| Owner (10%) | Bioglyco ApS | Current | |
| Founder | SCIENCE VENTURES DENMARK A/S | Current | |
| Founder | Boysen Bio ApS | Current | |
| Founder | Zahle Holding ApS | Current | |
| Founder | Røssel Invest APS | Current | |
| Founder | JMJ Holding ApS | Current | |
| Founder | Bioglyco ApS | Current |
The CEOs' other companies
Anders Boysen – 1 other companies
- GlyProVac ApS Active
Address history (0 moves)
| Rørhatten 4, 5220 Odense SØ |
Other companies at the same address
- Bioglyco ApS Active
- Boysen Bio ApS Active
- GlyProVac ApS Active
Similar companies in Odense
- BILBIX HOLDING ApS Odense SV
- KLC HOLDING ApS Odense NV
- J & J HOLDING AF 01.07.99 ApS Odense SV
- FLEMMING JOHANSEN HOLDING ApS Odense SV
- HS METALSERVICE ApS Odense C
- HABICO A/S Odense S
- THORMOSE HOLDING ApS Odense SV
- NORDISK KLIMA HOLDING A/S Odense C
- Fremaka Holding ApS Odense N
- NYKJÆR HOLDING ApS Odense C
- B.S. ODENSE HOLDING ApS Odense NV
- PFEIFFER HOLDING ApS Odense S
Questions and answers about GlycoPharma Holding ApS
Has GlycoPharma Holding ApS gone bankrupt?
No, GlycoPharma Holding ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of GlycoPharma Holding ApS?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of GlycoPharma Holding ApS?
Anders Boysen is the CEO of GlycoPharma Holding ApS.
Who is the auditor of GlycoPharma Holding ApS?
GlycoPharma Holding ApS most recently used PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab.
When was GlycoPharma Holding ApS founded?
GlycoPharma Holding ApS was founded on 28 June 2018.
What is the equity of GlycoPharma Holding ApS?
Equity was DKK 684k according to the annual report for the period ending 30 June 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.